 | • レポートコード：GIR-23F3842 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Ivosidenib Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のイボシデニブ薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 イボシデニブ薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・60錠、30錠 アプリケーション別セグメントは次のように区分されます。 ・病院、薬局 世界のイボシデニブ薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Agios Pharmaceuticals 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - イボシデニブ薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：60錠、30錠 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局 - 世界のイボシデニブ薬市場規模・予測 - 世界のイボシデニブ薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Agios Pharmaceuticals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：60錠、30錠 ・アプリケーション別分析2017年-2028年：病院、薬局 ・イボシデニブ薬の北米市場分析 - イボシデニブ薬の北米市場：タイプ別市場規模2017年-2028年 - イボシデニブ薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・イボシデニブ薬のヨーロッパ市場分析 - ：イボシデニブ薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：イボシデニブ薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・イボシデニブ薬のアジア太平洋市場分析 - イボシデニブ薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - イボシデニブ薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・イボシデニブ薬の南米市場分析 - イボシデニブ薬の南米市場：タイプ別市場規模2017年-2028年 - イボシデニブ薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・イボシデニブ薬の中東・アフリカ市場分析 - イボシデニブ薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - イボシデニブ薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ivosidenib Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ivosidenib Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Ivosidenib Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 60 Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Ivosidenib Drugs include Agios Pharmaceuticals, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ivosidenib Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
60 Tablets
30 Tablets
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Ivosidenib Drugs market are listed below:
Agios Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ivosidenib Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ivosidenib Drugs, with price, sales, revenue and global market share of Ivosidenib Drugs from 2019 to 2022.
Chapter 3, the Ivosidenib Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ivosidenib Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ivosidenib Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ivosidenib Drugs.
Chapter 13, 14, and 15, to describe Ivosidenib Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ivosidenib Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ivosidenib Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 60 Tablets
1.2.3 30 Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Ivosidenib Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Ivosidenib Drugs Market Size & Forecast
1.4.1 Global Ivosidenib Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Ivosidenib Drugs Sales in Volume (2017-2028)
1.4.3 Global Ivosidenib Drugs Price (2017-2028)
1.5 Global Ivosidenib Drugs Production Capacity Analysis
1.5.1 Global Ivosidenib Drugs Total Production Capacity (2017-2028)
1.5.2 Global Ivosidenib Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ivosidenib Drugs Market Drivers
1.6.2 Ivosidenib Drugs Market Restraints
1.6.3 Ivosidenib Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Agios Pharmaceuticals
2.1.1 Agios Pharmaceuticals Details
2.1.2 Agios Pharmaceuticals Major Business
2.1.3 Agios Pharmaceuticals Ivosidenib Drugs Product and Services
2.1.4 Agios Pharmaceuticals Ivosidenib Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Ivosidenib Drugs Breakdown Data by Manufacturer
3.1 Global Ivosidenib Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Ivosidenib Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Ivosidenib Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Ivosidenib Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Ivosidenib Drugs Manufacturer Market Share in 2021
3.5 Global Ivosidenib Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Ivosidenib Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ivosidenib Drugs Market Size by Region
4.1.1 Global Ivosidenib Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Ivosidenib Drugs Revenue by Region (2017-2028)
4.2 North America Ivosidenib Drugs Revenue (2017-2028)
4.3 Europe Ivosidenib Drugs Revenue (2017-2028)
4.4 Asia-Pacific Ivosidenib Drugs Revenue (2017-2028)
4.5 South America Ivosidenib Drugs Revenue (2017-2028)
4.6 Middle East and Africa Ivosidenib Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Ivosidenib Drugs Sales in Volume by Type (2017-2028)
5.2 Global Ivosidenib Drugs Revenue by Type (2017-2028)
5.3 Global Ivosidenib Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Ivosidenib Drugs Sales in Volume by Application (2017-2028)
6.2 Global Ivosidenib Drugs Revenue by Application (2017-2028)
6.3 Global Ivosidenib Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Ivosidenib Drugs Sales by Type (2017-2028)
7.2 North America Ivosidenib Drugs Sales by Application (2017-2028)
7.3 North America Ivosidenib Drugs Market Size by Country
7.3.1 North America Ivosidenib Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Ivosidenib Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Ivosidenib Drugs Sales by Type (2017-2028)
8.2 Europe Ivosidenib Drugs Sales by Application (2017-2028)
8.3 Europe Ivosidenib Drugs Market Size by Country
8.3.1 Europe Ivosidenib Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Ivosidenib Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Ivosidenib Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Ivosidenib Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Ivosidenib Drugs Market Size by Region
9.3.1 Asia-Pacific Ivosidenib Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Ivosidenib Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Ivosidenib Drugs Sales by Type (2017-2028)
10.2 South America Ivosidenib Drugs Sales by Application (2017-2028)
10.3 South America Ivosidenib Drugs Market Size by Country
10.3.1 South America Ivosidenib Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Ivosidenib Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ivosidenib Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Ivosidenib Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Ivosidenib Drugs Market Size by Country
11.3.1 Middle East & Africa Ivosidenib Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Ivosidenib Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Ivosidenib Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Ivosidenib Drugs
12.3 Ivosidenib Drugs Production Process
12.4 Ivosidenib Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Ivosidenib Drugs Typical Distributors
13.3 Ivosidenib Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Ivosidenib Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Ivosidenib Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Agios Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Agios Pharmaceuticals Major Business
Table 5. Agios Pharmaceuticals Ivosidenib Drugs Product and Services
Table 6. Agios Pharmaceuticals Ivosidenib Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Ivosidenib Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Ivosidenib Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Ivosidenib Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Ivosidenib Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Ivosidenib Drugs Production Site of Key Manufacturer
Table 12. Ivosidenib Drugs New Entrant and Capacity Expansion Plans
Table 13. Ivosidenib Drugs Mergers & Acquisitions in the Past Five Years
Table 14. Global Ivosidenib Drugs Sales by Region (2017-2022) & (K Units)
Table 15. Global Ivosidenib Drugs Sales by Region (2023-2028) & (K Units)
Table 16. Global Ivosidenib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Ivosidenib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Ivosidenib Drugs Sales by Type (2017-2022) & (K Units)
Table 19. Global Ivosidenib Drugs Sales by Type (2023-2028) & (K Units)
Table 20. Global Ivosidenib Drugs Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Ivosidenib Drugs Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Ivosidenib Drugs Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Ivosidenib Drugs Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Ivosidenib Drugs Sales by Application (2017-2022) & (K Units)
Table 25. Global Ivosidenib Drugs Sales by Application (2023-2028) & (K Units)
Table 26. Global Ivosidenib Drugs Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Ivosidenib Drugs Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Ivosidenib Drugs Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Ivosidenib Drugs Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Ivosidenib Drugs Sales by Country (2017-2022) & (K Units)
Table 31. North America Ivosidenib Drugs Sales by Country (2023-2028) & (K Units)
Table 32. North America Ivosidenib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Ivosidenib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Ivosidenib Drugs Sales by Type (2017-2022) & (K Units)
Table 35. North America Ivosidenib Drugs Sales by Type (2023-2028) & (K Units)
Table 36. North America Ivosidenib Drugs Sales by Application (2017-2022) & (K Units)
Table 37. North America Ivosidenib Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Europe Ivosidenib Drugs Sales by Country (2017-2022) & (K Units)
Table 39. Europe Ivosidenib Drugs Sales by Country (2023-2028) & (K Units)
Table 40. Europe Ivosidenib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Ivosidenib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Ivosidenib Drugs Sales by Type (2017-2022) & (K Units)
Table 43. Europe Ivosidenib Drugs Sales by Type (2023-2028) & (K Units)
Table 44. Europe Ivosidenib Drugs Sales by Application (2017-2022) & (K Units)
Table 45. Europe Ivosidenib Drugs Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Ivosidenib Drugs Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Ivosidenib Drugs Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Ivosidenib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Ivosidenib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Ivosidenib Drugs Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Ivosidenib Drugs Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Ivosidenib Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Ivosidenib Drugs Sales by Application (2023-2028) & (K Units)
Table 54. South America Ivosidenib Drugs Sales by Country (2017-2022) & (K Units)
Table 55. South America Ivosidenib Drugs Sales by Country (2023-2028) & (K Units)
Table 56. South America Ivosidenib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Ivosidenib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Ivosidenib Drugs Sales by Type (2017-2022) & (K Units)
Table 59. South America Ivosidenib Drugs Sales by Type (2023-2028) & (K Units)
Table 60. South America Ivosidenib Drugs Sales by Application (2017-2022) & (K Units)
Table 61. South America Ivosidenib Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Ivosidenib Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Ivosidenib Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Ivosidenib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Ivosidenib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Ivosidenib Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Ivosidenib Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Ivosidenib Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Ivosidenib Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Ivosidenib Drugs Raw Material
Table 71. Key Manufacturers of Ivosidenib Drugs Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Ivosidenib Drugs Typical Distributors
Table 75. Ivosidenib Drugs Typical Customers
List of Figures
Figure 1. Ivosidenib Drugs Picture
Figure 2. Global Ivosidenib Drugs Revenue Market Share by Type in 2021
Figure 3. 60 Tablets
Figure 4. 30 Tablets
Figure 5. Global Ivosidenib Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Ivosidenib Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Ivosidenib Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Ivosidenib Drugs Sales (2017-2028) & (K Units)
Figure 11. Global Ivosidenib Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global Ivosidenib Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global Ivosidenib Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Ivosidenib Drugs Market Drivers
Figure 15. Ivosidenib Drugs Market Restraints
Figure 16. Ivosidenib Drugs Market Trends
Figure 17. Global Ivosidenib Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Ivosidenib Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Ivosidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Ivosidenib Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Ivosidenib Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Ivosidenib Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Ivosidenib Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Ivosidenib Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Ivosidenib Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Ivosidenib Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Ivosidenib Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Ivosidenib Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Ivosidenib Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Ivosidenib Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Ivosidenib Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Ivosidenib Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Ivosidenib Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Ivosidenib Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Ivosidenib Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Ivosidenib Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Ivosidenib Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Ivosidenib Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Ivosidenib Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Ivosidenib Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Ivosidenib Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Ivosidenib Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Ivosidenib Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Ivosidenib Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Ivosidenib Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Ivosidenib Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Ivosidenib Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Ivosidenib Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Ivosidenib Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Ivosidenib Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Ivosidenib Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Ivosidenib Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Ivosidenib Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Ivosidenib Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Ivosidenib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Ivosidenib Drugs in 2021
Figure 76. Manufacturing Process Analysis of Ivosidenib Drugs
Figure 77. Ivosidenib Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
| 【イボシデニブ薬について】 イボシデニブ薬（Ivosidenib）は、主に血液がんの治療に用いられる分子標的薬であり、特定の遺伝子変異に対する治療選択肢を提供します。この薬は、特に急性骨髄性白血病（AML）や前骨髄球性白血病（APL）などの疾患に対して有効な治療法として注目されています。 イボシデニブは、がん細胞内での特定の酵素、すなわちIDH1（イソクエン酸脱水素酵素1）を阻害することによって機能します。IDH1は、細胞のエネルギー代謝や生理的な機能に重要な役割を果たしている酵素です。しかし、特定の変異がこの酵素に生じると、がん細胞の異常な増殖や生存を促進する化合物を生成することになります。イボシデニブはこの異常な酵素活性を抑制することによって、がん細胞の成長を阻止し、患者の予後を改善することが期待されているのです。 主な特徴として、イボシデニブは経口投与が可能であり、患者にとっての服用の容易さが大きな利点の一つとされています。この薬を使った治療は、主に新たに診断された急性骨髄性白血病のうち、特定のIDH1遺伝子変異を持つ患者に対して行われます。さらに、化学療法が効果を示さない場合や再発した患者においても、イボシデニブの使用が推奨されることがあります。 イボシデニブの効果については、臨床試験によって示されており、その効果が確認されています。特に、IDH1変異を持つAML患者では、治療に対する反応が良好であることが証明されています。これらの患者の中には、完全寛解を達成する者も多く、従来の治療法では得られないような治療効果が期待されています。 用途に関しては、主に急性骨髄性白血病に焦点を当てていますが、他のがんタイプにおけるIDH1変異の影響も研究されており、例えば、いくつかの固形腫瘍に対する可能性も探られています。このように、イボシデニブはまだ広がりを見せている分野であり、今後、さらなる適応症が認可される可能性があります。 関連技術としては、がん遺伝子解析やバイオマーカーの同定が挙げられます。IDH1遺伝子変異を正確に特定することは、イボシデニブの治療を成功させるために不可欠です。このため、さまざまな診断技術が開発されており、次世代シークエンシングやPCR（ポリメラーゼ連鎖反応）などの技術が用いられています。これにより、患者の遺伝子背景に基づいた個別化医療の実現に近づいています。 加えて、イボシデニブは、他の治療法と併用することによっても、その効果を高める可能性があります。例えば、従来の化学療法と組み合わせることで、相乗効果を得ることが期待されています。このような併用療法の研究も進行中であり、今後の臨床研究によってその実用性が検証されることが望まれます。 副作用に関しては、イボシデニブは比較的一般的に許容される治療法ですが、すべての薬剤と同様に副作用が存在します。主な副作用には、肝機能障害、発熱、感染症のリスク増加、消化器症状（例えば、腹痛や吐き気）、疲労感などがあります。これらの副作用は、患者によって異なる反応を示すことがあり、注意深いモニタリングが重要です。 イボシデニブの開発には、多くの研究と臨床試験が関与しており、がん治療における分子標的療法の進展を象徴するものとなっています。特に、遺伝子変異に基づいて個別化された治療法の重要性が増している現代において、イボシデニブは新たな治療パラダイムを提供する薬剤としての位置付けを得ています。 今後の研究では、より多くの患者に対する適応可能性の探求や、他の在来療法との組み合わせによる効果の向上、長期的な安全性に関するデータの収集が求められています。イボシデニブは、現代医療におけるがん治療の新たな武器として、今後もその重要性が増していくことが予想されます。 |
• 日本語訳：イボシデニブ薬のグローバル市場2022年
• レポートコード：GIR-23F3842 ▷ お問い合わせ（見積依頼・ご注文・質問）